Synovo Hip Implant Complications

You may be eligible for compensation if you had a total hip replacement after 2018 using:

Endotec BP devices

Synovo Preserve

Synovo Total Hip Replacement System

The FDA has issued a “Do Not Use” warning regarding Synovo Total Hip System devices, including:

Acetabular Bearing

Acetabular Fixation Cup

Femoral Resurfacing Cup

Seeger Weiss is investigating claims of device failure in Synovo Total Hip Replacement System devices.

People who received a Synovo Total Hip Replacement System and experienced complications or required hip revision surgery may be eligible for compensation.

FDA Synovo Hip Warning

The U.S. Food and Drug Administration (FDA) warned Surgeons and Surgical Centers regarding Synovo Total Hip Replacement System Devices. Synovo Total Hip Replacement System has also been known as Synovo Preserve and Endotec BP.

The January 2024 warning advises that Synovo Total Hip System devices manufactured after 2018 should not be used in hip implant procedures and states that the devices may not meet FDA guidelines.

The FDA recommends that devices should not be purchased or implanted and that they be removed from inventory due to a high risk of device failure.

Complications Linked to Synovo Hip Replacement Devices

A higher-than-expected risk of complications and adverse events has been linked to the use of the Synovo Total Hip Replacement System components.

Patients have reported symptoms including:

• Grinding or other noises
• Hip weakness
• Inability to bear weight
• Increasing pain
• Knee weakness
• Loosening hardware

The FDA has not recommended that the devices be removed from patients who are not experiencing difficulties but has recommended that patients should be closely monitored and that symptoms be reported to a health provider immediately.

We encourage people who received a Synovo Total Hip Replacement System and experienced complications or required hip revision surgery to request a free, private case review to qualify for potential compensation.